首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of clinical and experimental hepatology

缩写:

ISSN:0973-6883

e-ISSN:2213-3453

IF/分区:3.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1733
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Adham E Obeidat,Linda L Wong Adham E Obeidat
Background: Spontaneous rupture of hepatocellular carcinoma (HCC) is a potentially fatal complication and the third leading cause of death in patients with HCC after tumor progression and liver failure. Previous studies s...
Abhinav Anand,Amit A Singh,Anshuman Elhence et al. Abhinav Anand et al.
Background and aims: Nonalcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease worldwide. Despite the high prevalence, no screening recommendations yet exist. We designed a prospective obser...
Somashekara Hosaagrahara Ramakrishna,Mohan Babu Kasala,Karnan Perumal et al. Somashekara Hosaagrahara Ramakrishna et al.
ABO-incompatible living donor liver transplantation (ABOi-LDLT) is on the rise as a viable option in countries with limited access to deceased donor grafts. While reported outcomes of ABOi-LT in children are similar to ABO- Compatible liver...
Surender Singh,Sunil Taneja,Puneeta Tandon et al. Surender Singh et al.
Background & aims: There is no "gold standard" tool for the assessment of frailty in cirrhosis. This study compares Liver Frailty Index (LFI), Short Physical Performance Battery (SPPB), Fried Frailty Criteria (FFC), and C...
Shahnawaz Bashir,Subhash Gupta,Shaleen Agarwal et al. Shahnawaz Bashir et al.
Partial splenic embolization (PSE) is a minimally invasive endovascular procedure for the treatment of hypersplenism. This procedure is normally done by catheterization of the splenic artery, which if ligated during surgery, makes the proce...
Prachi Tiwari,Harshita Katiyar,Praveer Rai et al. Prachi Tiwari et al.
In India, hepatitis C virus (HCV) infection is treated with sofosbuvir in combination with NS5A inhibitor (Daclatasvir, Ledipasvir, or Velpatasvir). A small proportion of them fail to achieve sustained virological response at 12 weeks (SVR1...